Proteolipid in Peritoneal Effluent of Capd Patients

18th Report of Australian & New Zealand Dialysis & Transplant Registry, 1995.

Dobbie J.W. New concepts in molecular biology and ul- trastructural pathology of the peritoneum: their significance for peritoneal dialysis. Am J Kidney Dis 1990; xv: 97–109.

Hills B.A. , Butler B.D. , Barrow R.E. Boundary lubrication imparted by pleural surfactants and their identification. J Appl Physiol 1982; 53: 463–9.

Hills B.A. , Butler B.D. Surfactants identified on the pericardium and their ability to impart boundary lubrication. Ann Biomed Eng 1985; 13: 573–86.

Graham G.R. , Torchia M.J. , Dankewich K.A. , Ferguson I.A. Surface active material in peritoneal effluent of CAPD patients. Perit Dial Bull 1985; 5: 109–11.

Seragton C.J. Morphology of surfactant producing cells and of the alveolar lining. In: Roberston B. , Van Golde L.M.G. , Battenburg J.J. , eds. Pulmonary surfactant: from molecular biology to clinical practice. Amsterdam: Elsvier, 1993: 68–118.

Dobbie J.W. , Lloyd J.K. Mesothelium secretes lamellar bodies in a similar manner to type II pneumocyte secretion of surfactant. Perit Dial Int 1989; 9: 215–19.

Whitsett J.A. , Weaver T.E. The biology of surfactant associated proteins. In: Bourbon J.R. , ed. Pulomary surfactant: biochemical, functional, regulatory, and clinical concepts. Boca Raton, FL: CRC Press, 1991: 127–42.

Hills B.A. The biology of surfactant. Cambridge: Cam bridge University Press, 1988.

Hills B.A. , Kirwood C.A. Gastric mucosal barrier: Barrier to hydrogen ions imparted by gastric surfactant in vitro. Gut 1992; 33: 1039–41.

Hills B.A. A hydrophobic oligolamellar lining to surfaces in various tissues: a possible ubiquitous barrier. Med Sci Res 1992; 20: 543–50.

Benjamins J.A. , Morell P. Proteins of myelin and their metabolism. Neurochem Res 1978; 3: 137–74.

Campbell S. , Clarke P. , Hawley C. , Wigan M. , Kerlin P. , Butler J. Sclerosing peritonitis -identification in diagnostic clinical and radiological features. Am J Kidney Dis 1994; 24: 819–25.

Dobbie J.W. Pathogenesis of peritoneal fibrosing syndrome (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12: 14–21.

Ziegler C. , Torchia M. , Graham G. , Ferguson I. Peritoneal surface-active material in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int 1989; 9: 47–9.

Beavis J. , Harwood J.L. , Coles G.A. , Williams J.D. Intraperitoneal phosphatidylcholine levels in patients on continuous ambulatory peritoneal dialysis do not correlate with adequacy of ultrafiltration. J Am Soc Nephrol 1993; 3: 1954–60.

Krack G. , Viglino G. , Cavalli P.L. , Gandolfo C. , Magliano G. , Cantaluppi A. Intraperitoneal administration of phosphatidylcholine improves ultrafiltration in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1992; 12: 359–64.

Breborowicz A. , Wierczorowska K. , Witowski J. , Martis L. , Oreopoulos D.G. Phosphatidylcholine and chondroitin sulphate in peritoneal dialysis fluids to preserve membrane function. Perit Dial Int 1994; 14(Suppl 3): 139–42.

De Vecchi A. , Caseinovo C. , Guerra L. , Scalamogna A. Phosphotidylcholine administration in continuous ambulatory peritoneal (CAPD) patients with reduced ultrafiltration. Perit. Dial Int 1989; 9: 207–10.

Twardowski A.J. , Nolph K.D. , Khanna R. , Prowant B.F. , Ryan L.P. , Moore H.L. Peritoneal equilibration test. Perit Dial Bull 1987; 7: 138–47.

Folch J. , Lees M. , Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 1956; 266: 497–509.

Bohlen P. , Stein S. , Dairman W. , Udenfriend S. Fluorometric assay of proteins in the nanogram range. Arch Biochem Biophys 1973; 155: 213–20.

Rouser F. , Siakotos A.N. , Fleischer S. Quantitative analysis of phospholipids by TLC and phosphorus analysis of spots. Lipids 1966; 1: 85–6.